Data Aquisition for Optimization of Coronary Artery Disease Algorithm
Completed
- Conditions
- Coronary Artery Disease
- Registration Number
- NCT01090947
- Lead Sponsor
- Acarix
- Brief Summary
The purpose of the study is to optimize an already existing algorithm for diagnosing atherosclerosis of the coronary arteries (CAD, Coronary Artery Disease).
- Detailed Description
Acoustic information from the heart is obtained from patients suffering from Coronary Artery Disease. The acoustic signals are evaluated as indicators for CAD.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 729
Inclusion Criteria
- Age minimum 18 years
- Referred to CAG on suspicion of CAD
- Stabile angina without ACS
- Signed informed consent
Exclusion Criteria
- ACS
- Previous bypass operation
- Previous heart transplant(incl. mechanical or artificial)
- Pregnancy
- Damaged skin on examination location
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity versus 1-specificity as a function of cut-off values on the 'Cardiac Noise Marker' scale here under Sensitivity by suitable cut-off value on the 'Cardiac Noise Marker' scale and Specificity with same cut-off value. The first testday
- Secondary Outcome Measures
Name Time Method Observed differences in distribution of 'Cardiac Noise Marker' within three sub-groups. The first testday
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does the CAD algorithm target in coronary artery disease diagnosis?
How does acoustic signal evaluation compare to angiography in detecting coronary atherosclerosis?
What biomarkers are used in NCT01090947 for predicting CAD patient response to non-invasive diagnostics?
Are there adverse events associated with acoustic-based CAD detection methods in clinical practice?
What are the key differences between Acarix's algorithm and other non-invasive coronary artery disease diagnostic technologies?
Trial Locations
- Locations (1)
University Hospital of Copenhagen
🇩🇰Copenhagen, Denmark
University Hospital of Copenhagen🇩🇰Copenhagen, Denmark